- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07735078
Vestibular Balance-Cognition Dual-Task Digital System: Development of a Smart Rehabilitation Platform for the Elderly and Prediction of Balance Function Risks
26 de julho de 2026 atualizado por: National Yang Ming Chiao Tung University
This study is being done to better understand how vestibular problems and thinking abilities (such as attention and mental flexibility) are related in older adults, and how doing a balance task and a thinking task at the same time affects their performance.
Older adults will first complete questionnaires and simple paper-and-pencil tests of attention, memory, and mental rotation while seated.
They will then perform standing balance tasks on a portable force platform under different conditions (eyes open, eyes closed, standing on a foam surface) and will repeat some of the thinking tasks at the same time.
Next, participants will walk on a treadmill while wearing small motion sensors, both with and without added thinking tasks such as serial subtraction and digit reordering.
The total testing time is about 90 minutes.
Two groups will be included: healthy older adults and older adults who have had dizziness or falls in the past two years.
By comparing these groups, the study aims to provide a basis for designing future dual-task assessment and training programs to reduce balance problems and falls in older adults.
Visão geral do estudo
Status
Recrutamento
Condições
Tipo de estudo
Observacional
Inscrição (Estimado)
55
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Po-Yin Chen, PhD
- Número de telefone: 67166 +886-2-2826-7000
- E-mail: poyin1128@nycu.edu.tw
Estude backup de contato
- Nome: Quan-Chen Wu, MS
- Número de telefone: 65925 +886-2-2826-7000
- E-mail: kc1211.be14@nycu.edu.tw
Locais de estudo
-
-
Taipei
-
Taipei, Taipei, Taiwan, 112
- Recrutamento
- National Yang Ming Chiao Tung University, Department of Physical Therapy and Assistive Technology
-
Contato:
- Po-Yin Chen, Assistant Professor, PhD
- Número de telefone: 67166 +886-2-2826-7000
- E-mail: poyin1128@nycu.edu.tw
-
Contato:
- Quan-Chen Wu, Research Assistant, MS
- Número de telefone: 65925 +886-2-2826-7000
- E-mail: kc1211.be14@nycu.edu.tw
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Sim
Método de amostragem
Amostra Não Probabilística
População do estudo
Community-dwelling older adults aged 55 years and older without severe neurological, sensory, or musculoskeletal conditions, who can walk at least 30 meters independently or with a walking aid, communicate in Mandarin or Taiwanese, and safely participate in weekly moderate-intensity exercise sessions.
Descrição
Inclusion Criteria:
- Community-dwelling adults aged 55 years or older.
- Able to walk at least 30 meters independently or with the use of a walking aid.
- Able to understand the study procedures and communicate in Mandarin or Taiwanese.
- Adequate corrected vision to go out independently.
- Able to participate in 45-minute sessions of moderate-intensity exercise once per week.
Exclusion Criteria:
- Severe central or peripheral neurological diseases.
- Blindness or deafness.
- Inability to communicate verbally or to understand simple instructions.
- Current fractures or major joint injuries.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Healthy Older Adults
Community-dwelling older adults aged 55 years and older who are able to walk at least 30 meters independently or with a walking aid, can communicate in Mandarin or Taiwanese, have adequate corrected vision to go out independently, and can participate in 45-minute sessions of moderate-intensity exercise once per week.
Individuals with severe central or peripheral neurological diseases, blindness or deafness, inability to communicate verbally or understand instructions, or current fractures or major joint injuries will be excluded.
|
Participants undergo a series of static and dynamic balance and gait assessments in a motion analysis laboratory while wearing body-segment inertial measurement units (IMUs).
The sensors provide real-time signals for interaction with the evaluation system during single-task and dual-task standing and walking tests.
Participants complete a battery of self-report questionnaires and paper-based cognitive tests after explanation by a physical therapist.
Instruments include dizziness and balance scales, the Activities-specific Balance Confidence (ABC) scale, and cognitive tests such as the WAIS-III Taiwan Digit Odd-Even Sequencing Test, Taiwan Stroop Word-Color Test, path judgment tasks, and mental rotation tasks.
Questionnaires are administered verbally and responses recorded in writing.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Gait speed
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Average forward velocity of whole-body progression during walking, calculated as total distance divided by time.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Stride length (m)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Linear distance between two consecutive initial contacts of the same foot.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Step width (m)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Mediolateral distance between consecutive foot placements, representing base of support during gait.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Cadence (steps/min)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Number of steps taken per minute during walking.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Step-to-step variability (%)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Variability of consecutive steps, typically quantified as the coefficient of variation of stride time or step length.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Trunk angular velocity (degrees/s)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Rate of change in trunk segment orientation over time, derived from rotational kinematics.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Trunk angular displacement (degrees)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Magnitude of trunk segment rotation relative to a reference orientation.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Center-of-mass displacement (m)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Spatial excursion of the body's center of mass, typically analyzed in anterior-posterior and mediolateral directions during standing.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Response time (s or ms)
Prazo: Baseline laboratory assessment (single visit in year 1)
|
Time elapsed between stimulus onset and initiation of a motor response.
|
Baseline laboratory assessment (single visit in year 1)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Montreal Cognitive Assessment-Taiwan version score (0-30points)
Prazo: Baseline laboratory assessment
|
Total score on the Montreal Cognitive Assessment-Taiwan version, representing global cognitive function.
|
Baseline laboratory assessment
|
|
Path tracing completion time (s)
Prazo: Baseline laboratory assessment
|
Time required to complete the Color Trails Test-1 task.
|
Baseline laboratory assessment
|
|
Stroop test score (count as PR1-99%)
Prazo: Baseline laboratory assessment
|
Score of Stroop-type task, indicating inhibitory control and selective attention.
|
Baseline laboratory assessment
|
|
Working memory completion time (s)
Prazo: Baseline laboratory assessment
|
Time required to complete the Color Trails Test-2 task.
|
Baseline laboratory assessment
|
|
Mental rotation accuracy (number of correct responses)(0-16)
Prazo: Baseline laboratory assessment
|
Number of correct responses in the mental rotation task, reflecting visuospatial processing ability.
|
Baseline laboratory assessment
|
|
Mental rotation completion time (s)
Prazo: Baseline laboratory assessment
|
Time required to complete the mental rotation task.
|
Baseline laboratory assessment
|
|
Activities-specific Balance Confidence score (0-100 points)
Prazo: Baseline laboratory assessment
|
Total score on the Activities-specific Balance Confidence (ABC) scale, reflecting perceived balance confidence during daily activities; higher scores indicate greater confidence.
|
Baseline laboratory assessment
|
|
Dizziness Handicap Inventory score (0-100points)
Prazo: Baseline laboratory assessment
|
Total score on the Dizziness Handicap Inventory (DHI), representing self-perceived handicap due to dizziness; higher scores indicate greater disability.
|
Baseline laboratory assessment
|
|
Hospital Anxiety and Depression Scale - Anxiety score (0-21 points)
Prazo: Baseline laboratory assessment
|
Subscale score of the HADS assessing anxiety symptoms; higher scores indicate greater anxiety.
|
Baseline laboratory assessment
|
|
Hospital Anxiety and Depression Scale - Depression score (0-21 points)
Prazo: Baseline laboratory assessment
|
Subscale score of the HADS assessing depressive symptoms; higher scores indicate greater depression.
|
Baseline laboratory assessment
|
|
Visual Vertigo Analogue Scale score ( 0-90points)
Prazo: Baseline laboratory assessment
|
Self-reported severity of visually induced dizziness measured using a visual analogue scale; higher scores indicate greater symptom severity.
|
Baseline laboratory assessment
|
|
Dynamic Gait Index score (0-24 points)
Prazo: Baseline laboratory assessment
|
Total score on the Dynamic Gait Index, based on performance across eight functional gait tasks; lower scores indicate poorer gait performance and increased fall risk.
|
Baseline laboratory assessment
|
|
Tinetti total score (0-28 points)
Prazo: Baseline laboratory assessment
|
Combined score of balance and gait subscales in the Tinetti assessment; lower scores indicate higher overall fall risk.
|
Baseline laboratory assessment
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Po-Yin Chen, PhD, National Yang Ming Chiao Tung University, Department of Physical Therapy and Assistive Technology
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
10 de fevereiro de 2025
Conclusão Primária (Estimado)
31 de julho de 2026
Conclusão do estudo (Estimado)
11 de março de 2027
Datas de inscrição no estudo
Enviado pela primeira vez
8 de julho de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
26 de julho de 2026
Primeira postagem (Real)
29 de julho de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
29 de julho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
26 de julho de 2026
Última verificação
1 de junho de 2026
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Manifestações Neurológicas
- Distúrbios da Sensação
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Tontura
- Qualidade, acesso e avaliação da assistência médica
- Técnicas de investigação
- Métodos epidemiológicos
- Coleta de dados
- Mecanismos de avaliação de saúde
- Qualidade de assistência médica
- Saúde pública
- Meio ambiente e saúde pública
- Pesquisas e questionários
Outros números de identificação do estudo
- NYCU114022AF
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
SIM
Descrição do plano IPD
De-identified individual participant data (IPD) will be shared for research purposes.
The data set will include key demographic variables, vestibular-related cognitive test scores, instrumented balance and gait parameters from wearable inertial sensors, static balance metrics, and questionnaire/scale scores (e.g., ABC, DHI, VVAS, HADS, DGI, Tinetti, MoCA-TW), with all direct identifiers removed.
A detailed data dictionary and description of derived variables will be provided to support secondary analyses.
Prazo de Compartilhamento de IPD
IPD will be made available within 12 months after publication of the primary results manuscript and will remain accessible for at least 5 years thereafter.
Critérios de acesso de compartilhamento IPD
De-identified IPD will be shared with qualified researchers from academic or healthcare institutions for non-commercial research on vestibular, balance, gait, cognitive, or related geriatric health topics.
Investigators must submit a brief proposal specifying objectives, planned analyses, and ethical approvals.
Proposals will be reviewed by the study team, and, if approved, data will be provided via secure transfer following execution of a data use agreement that requires protection of confidentiality, prohibits re-identification, and mandates appropriate citation of the original trial in all publications.
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .